Esomeprazole Clinical Trials

• Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis
  ClinicalTrials.gov Identifier: NCT00123656 - Recruiting
  Esophagitis
  
• High Dosage Esomeprazole and Baclofen for Therapy of Gastroesophageal Reflux Disease
  ClinicalTrials.gov Identifier: NCT00461604 - Recruiting
  Patients With Persistent Objectified Gastroesophageal Reflux and Reflux-Associated Symptoms Despite PPI-Therapy With 40mg Esomeprazole
  
• Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With Esomeprazole in NUD Patients
  ClinicalTrials.gov Identifier: NCT00222131 - Active, not recruiting
  Indigestion
  
• Esomeprazole and Symptomatic Response in Patients With or Without an Elevated Risk for NSAID-Associated GI Damage
  ClinicalTrials.gov Identifier: NCT00524329 - Active, not recruiting
  Heartburn; Bloating; Regurgitation
  
• Proton Pump Inhibitor Treatment Stop
  ClinicalTrials.gov Identifier: NCT00120315 - Active, not recruiting
  Dyspepsia
  
• An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 Mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)
  ClinicalTrials.gov Identifier: NCT00242736 - Completed
  GERD
  
• Effect of Acid Suppression With Esomeprazole on Vocal Cord Granulomas
  ClinicalTrials.gov Identifier: NCT00567658 - Recruiting
  Larynx Disease
  
• Phase 3/Safety & Efficacy of Esomeprazole in Infants
  ClinicalTrials.gov Identifier: NCT00468559 - Recruiting
  Gastroesophageal Reflux Disease (GERD)
  
• A Comparison of Gastric pH Control With High Dose Intravenous or Oral Esomeprazole
  ClinicalTrials.gov Identifier: NCT00164788 - Recruiting
  Gastrointestinal Hemorrhage
  
• Evaluation of Esomeprazole in Treating GERD in Head and Neck Cancer Patients Exposed to Radiation Therapy.
  ClinicalTrials.gov Identifier: NCT00222079 - Recruiting
  Gastro-Esophageal Reflux
  
• Efficacy and Safety of Esomeprazole Once Daily for the Treatment of GERD in Neonatal Patients
  ClinicalTrials.gov Identifier: NCT00427635 - Recruiting
  GERD
  
• Nexium (Esomeprazole) in Symptom Adapted Therapy in GERD Patients
  ClinicalTrials.gov Identifier: NCT00444275 - Recruiting
  GERD
  
• Efficacy and Safety Study of Esomeprazole vs Omeprazole to Treat Acute Non-Variceal Upper Gastrointestinal Bleeding
  ClinicalTrials.gov Identifier: NCT00402259 - Recruiting
  Gastrointestinal Hemorrhage
  
• Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma
  ClinicalTrials.gov Identifier: NCT00317044 - Recruiting
  Asthma; GERD
  
• In Vivo Quantification of Dental Demineralisation Using Optical Coherence Tomography Before and After Double-Blind, Randomised Treatment With Esomeprazole or Placebo of Patients With Dental Erosions
  ClinicalTrials.gov Identifier: NCT00564330 - Recruiting
  Tooth Erosion
  
• Esomeprazole With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett's Metaplasia
  ClinicalTrials.gov Identifier: NCT00357682 - Recruiting
  Esophageal Cancer; Precancerous/Nonmalignant Condition
  
• Esomeprazole With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus
  ClinicalTrials.gov Identifier: NCT00474903 - Recruiting
  Esophageal Cancer; Precancerous/Nonmalignant Condition
  
• Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer
  ClinicalTrials.gov Identifier: NCT00471029 - Recruiting
  Peptic Ulcer
  
• Efficacy and Safety Study of Esomeprazole 20mg qd vs Ranitidine 150mg Bid in Patients With an NSAID-Induced Gastric Ulcer
  ClinicalTrials.gov Identifier: NCT00401752 - Recruiting
  Gastric Ulcer
  
• Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on LDA
  ClinicalTrials.gov Identifier: NCT00441727 - Recruiting
  Gastric Ulcer; Duodenal Ulcer
  
• Comparison of the Gastric Acid Suppressive Effects of Esomeprazole and Generic Omeprazole
  ClinicalTrials.gov Identifier: NCT00542347 - Recruiting
  Gastric Acid
  
• Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome
  ClinicalTrials.gov Identifier: NCT00079833 - Completed
  Zollinger-Ellison Syndrome
  
• A Study To Evaluate The Effects Of Repeat Dosing Of Esomeprazole On The Pharmacokinetics Of SB-751689 In Healthy People
  ClinicalTrials.gov Identifier: NCT00508534 - Not yet recruiting
  Osteoporosis
  
• Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori Infection
  ClinicalTrials.gov Identifier: NCT00455806 - Recruiting
  Helicobacter Pylori Infection; Chronic Gastritis
  
• Esomeprazole Treatment for Patients With Lymphocytic Gastritis
  ClinicalTrials.gov Identifier: NCT00455754 - Recruiting
  Lymphocytic Gastritis
  
• APE-Study: Ablation of Barrett's Mucosa vs. Surveillance Without Ablation in Patients Cured From Barrett's Cancer Combined With Randomization of Esomeprazole vs. Placebo for Symptomatic Reflux Control After Successful Barrett's Ablation
  ClinicalTrials.gov Identifier: NCT00546065 - Recruiting
  Barrett's Esophagus
  
• A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomperazole 40m
  ClinicalTrials.gov Identifier: NCT00464308 - Recruiting
  Gastro-Oesophageal Reflux
  
• Clinical Trial of Acid Reflux Therapy in Asthma
  ClinicalTrials.gov Identifier: NCT00069823 - Recruiting
  Asthma; Lung Diseases; Lung Diseases, Obstructive
  
• The Effect of Nexium on Transmucosal Esophageal Leak
  ClinicalTrials.gov Identifier: NCT00216788 - Not yet recruiting
  Reflux; Esophagitis; Barrett''s Esophagus
  
• Esomeprazole in PPI Failures - IMPROVE
  ClinicalTrials.gov Identifier: NCT00272701 - Completed
  Gastroesophageal Reflux Disease
  
• Esomeprazole and Gastric Emptying of Beer
  ClinicalTrials.gov Identifier: NCT00472550 - Completed
  Gastroesophageal Reflux; Heartburn
  
• Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs
  ClinicalTrials.gov Identifier: NCT00241514 - Completed
  GERD
  
• Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs
  ClinicalTrials.gov Identifier: NCT00241540 - Completed
  GERD
  
• Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD
  ClinicalTrials.gov Identifier: NCT00410592 - Completed
  Gastroesophageal Reflux Disease
  
• Study to Assess Management Strategies for the Use of Esomeprazole (Nexium) in Helicobacter Pylori Infected Patients
  ClinicalTrials.gov Identifier: NCT00574925 - Completed
  Gastroesophageal Reflux Disease (GERD)
  
• AGN 201904 Versus Esomeprazole in the Prevention of Aspirin-Induced Stomach or Upper Intestinal Damage in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00325715 - Completed
  Peptic Ulcer
  
• Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients
  ClinicalTrials.gov Identifier: NCT00241501 - Completed
  Gastroesophageal Reflux Disease (GERD)
  
• Acid-Associated Heartburn Symptoms and Dose of Esomeprazole
  ClinicalTrials.gov Identifier: NCT00206024 - Completed
  Heartburn
  
• An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients
  ClinicalTrials.gov Identifier: NCT00352261 - Completed
  Barrett's Esophagus
  
• Study of 24-Hour Intragastric pH Profiles of Esomeprazole 40 Mg and Lansoprazole 30 Mg in Healthy Volunteer Subjects
  ClinicalTrials.gov Identifier: NCT00230516 - Completed
  Healthy
  
• A Dose-Finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis.
  ClinicalTrials.gov Identifier: NCT00206245 - Completed
  GERD With Erosive Esophagitis
  
• A Dose-Finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis.
  ClinicalTrials.gov Identifier: NCT00206284 - Completed
  GERD Without Erosive Esophagitis
  
• Esomeprazole for Treatment of GERD in Pediatric Patients
  ClinicalTrials.gov Identifier: NCT00228527 - Completed
  Gastroesophageal Reflux Disease (GERD); Erosive Esophagitis; Non-Erosive Esophagitis
  
• Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs
  ClinicalTrials.gov Identifier: NCT00241553 - Completed
  NSAIDs; Upper GI Symptoms
  
• Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs
  ClinicalTrials.gov Identifier: NCT00241527 - Completed
  NSAIDs; Upper GI Symptoms
  
• Preventing Recurrent Ulcer Bleeding in Arthritis Patients Using Esomeprazole Plus Celecoxib
  ClinicalTrials.gov Identifier: NCT00365313 - Completed
  Arthritis; Bleeding Ulcer
  
• Study of Intragastric pH Profile After 5 Days Pantoprazole 40 Mg Iv Followed by Oral Esomeprazole 40 Mg Po or Oral Pantoprazole 40 Mg Po
  ClinicalTrials.gov Identifier: NCT00206050 - Completed
  Healthy
  
• Total Antioxidant Effects of Esomeprazole in Dyspeptic Patients Receiving Non-Steroidal Anti-Inflammatory Drugs
  ClinicalTrials.gov Identifier: NCT00443963 - Terminated
  Dyspepsia
  
• A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00332748 - Terminated
  Cancer